Drugs / LIVACT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT02837302 Comparator | Nov 2012 → Dec 2017 | cirrhosis of liver | Kyungpook National University Hospital | Unknown | No outcome recorded |
| — | NCT01434524 Comparator | Apr 2007 → Oct 2008 | liver cancer | Kochi University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Livact | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02837302 ↗ |
| Modality | Other / unclassified | “oral branched-chain amino acid supplement” NCT02837302 ↗ |
| Route | Oral | “oral supplementation with BCAA” NCT01434524 ↗ |